Gyeonggi, South Korea

Taeyoung Oh

This inventor holds 1 USPTO granted patent. Top assignee: Dong-A Pharm. Co., Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taeyoung Oh. Retrieved from https://idiyas.com/inventor/taeyoung-oh-d247ror8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Taeyoung Oh: Innovator in Pharmaceutical Development

Introduction

Taeyoung Oh is a notable inventor based in Kyunggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of male sexual dysfunctions.

Latest Patents

Taeyoung Oh holds a patent for "Pyrazolopyrimidinone derivatives for the treatment of impotence." This invention relates to pyrazolopyrimidinone derivatives, their preparation methods, and pharmaceutical compositions that include these derivatives. The compounds developed by Oh demonstrate efficacy in treating impotence while minimizing side effects.

Career Highlights

Taeyoung Oh is associated with Dong-a Pharm. Co., Ltd., a prominent pharmaceutical company. His work focuses on innovative solutions that address critical health issues, showcasing his commitment to improving patient outcomes.

Collaborations

Some of his coworkers include Moohi Yoo and Wonbae Kim, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Taeyoung Oh's innovative work in developing pyrazolopyrimidinone derivatives highlights his role as a key figure in pharmaceutical advancements. His contributions are paving the way for more effective treatments in the field of male sexual health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…